Continuous Renal Replacement Therapy: Application of Kidney Disease Improving Global Outcomes Guidelines for Treatment Prescription in Dogs With Acute Kidney Injury and Outcome Prediction
Journal of Veterinary Internal Medicine · 2025-07-01 · 39 (4)
DOI: 10.1111/jvim.70183 ↗At a glance
Leitlinie in Journal of Veterinary Internal Medicine, published online on 2025-07-01. Written by Hilli Raskansky and 2 co-authors. Institution: Ben-Shemen Specialist Referral Center, Ben Shemen, Israel. Major MEDLINE topics: Dog Diseases, Acute Kidney Injury, Continuous Renal Replacement Therapy. Cited 1 times so far (Crossref); 71 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Background
Continuous renal replacement therapy (CRRT) is routinely used in human patients with acute kidney injury (AKI) but studies in dogs are scarce.
Objective
To describe CRRT in dogs and assess the utility of a previously validated scoring system for dogs with AKI undergoing hemodialysis, and the Acute Patient Physiological and Laboratory Evaluation (APPLEFull/APPLEFast) scores, for outcome prediction. Animals Thirty, client-owned dogs.
Methods
Cases were retrospectively reviewed. Prognostic scores were calculated upon admission and before CRRT initiation. The CRRT effluent dose followed the KDIGO guidelines. Receiver operating characteristic curves (ROCC) were constructed to evaluate the prognostic utility of these scores.
Results
Median (IQR) serum creatinine (mg/dL) at CRRT initiation, at discharge, and 3 months after discharge were 9.4 (7.4), 3.4 (1), and 1.3 (0.3) respectively. Median (IQR) treatment duration and total number of treatments were 24 (18.5) h and 2 (2) treatments, respectively. The prescribed median (IQR) CRRT effluent dose was 29 (18.5) mL/kg/h. Median (IQR) overall time-average concentration for urea and creatinine were 92 (60) mg/dL and 3.7 (1.7) mg/dL, respectively. The normalized weekly median (IQR) standardized Kt/V was 2.41 (2.29). Eleven dogs (37%) survived to discharge/3-months after treatment. Areas under the ROCC for the APPLEFull/APPLEFast scores before CRRT initiation were 0.99 (95% CI, 0.99–1.00) and 0.91 (95% CI, 0.81–1.00), respectively. Optimal cutoff points were < 35 for the APPLEFull and < 23 for the APPLEFast, yielding sensitivities/specificities of 100% (95% CI, 74.12%–100.0%)/94.7% (95% CI, 75.36%–99.73%) and 90.9% (95% CI, 62.26%–99.53%)/78.95% (95% CI, 56.67%–91.49%), respectively.
Conclusion
The APPLE scores, unlike clinicopathological findings or the Segev score, proved to be a highly discriminatory prognostic tool. Additionally, the human-derived, KDIGO guideline-based CRRT protocol proved safe and efficacious in dogs undergoing CRRT.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Ben-Shemen Specialist Referral Center, Ben Shemen, Israel.
ORCID profiles: Ran Nivy
Cite
APA
Raskansky, H., Bruchim, Y., & Nivy, R. (2025). Continuous Renal Replacement Therapy: Application of Kidney Disease Improving Global Outcomes Guidelines for Treatment Prescription in Dogs With Acute Kidney Injury and Outcome Prediction. Journal of Veterinary Internal Medicine, 39(4). https://doi.org/10.1111/jvim.70183
Vancouver
Raskansky H, Bruchim Y, Nivy R. Continuous Renal Replacement Therapy: Application of Kidney Disease Improving Global Outcomes Guidelines for Treatment Prescription in Dogs With Acute Kidney Injury and Outcome Prediction. Journal of Veterinary Internal Medicine. 2025;39(4). doi:10.1111/jvim.70183
BibTeX
@article{Raskansky2025,
author = {Raskansky, Hilli and Bruchim, Yaron and Nivy, Ran},
title = {Continuous Renal Replacement Therapy: Application of Kidney Disease Improving Global Outcomes Guidelines for Treatment Prescription in Dogs With Acute Kidney Injury and Outcome Prediction},
journal = {Journal of Veterinary Internal Medicine},
year = {2025},
volume = {39},
number = {4},
doi = {10.1111/jvim.70183}
}
EUVIMED